TwHF

DRUG2 trials

Sponsors

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Beijing 302 Hospital

Conditions

Human Immunodeficiency VirusRheumatoid Arthritis

Phase 1

Tripterygium Wilfordii Hook F (TwHF) Treatment for Immune Non-responders With HIV-1 Infection

Beijing 302 HospitalHuman Immunodeficiency Virus

Start: 2012-06-30End: 2016-12-31Target: 60Updated: 2015-08-17

Phase 2

Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine

CompletedNCT00062465

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Rheumatoid Arthritis

Start: 2003-06-30End: 2006-03-31Target: 157Updated: 2008-03-04